SE442268B - Forfarande for framstellning av dinatriumsaltet av 1,3-bis(2-karboxikromon-5-yloxi)propan-2-ol i specifik form - Google Patents

Forfarande for framstellning av dinatriumsaltet av 1,3-bis(2-karboxikromon-5-yloxi)propan-2-ol i specifik form

Info

Publication number
SE442268B
SE442268B SE7700888A SE7700888A SE442268B SE 442268 B SE442268 B SE 442268B SE 7700888 A SE7700888 A SE 7700888A SE 7700888 A SE7700888 A SE 7700888A SE 442268 B SE442268 B SE 442268B
Authority
SE
Sweden
Prior art keywords
carboxicromon
ols
yloxy
propan
bis
Prior art date
Application number
SE7700888A
Other languages
English (en)
Swedish (sv)
Other versions
SE7700888L (sv
Inventor
K Brown
N A Stevenson
W F Kirk
C Booles
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26238506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE442268(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB3672/76A external-priority patent/GB1562901A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of SE7700888L publication Critical patent/SE7700888L/xx
Publication of SE442268B publication Critical patent/SE442268B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7700888A 1976-01-30 1977-01-27 Forfarande for framstellning av dinatriumsaltet av 1,3-bis(2-karboxikromon-5-yloxi)propan-2-ol i specifik form SE442268B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3672/76A GB1562901A (en) 1976-01-30 1976-01-30 Disodium cromoglycate
GB5113676 1976-12-08

Publications (2)

Publication Number Publication Date
SE7700888L SE7700888L (sv) 1977-07-31
SE442268B true SE442268B (sv) 1985-12-16

Family

ID=26238506

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7700888A SE442268B (sv) 1976-01-30 1977-01-27 Forfarande for framstellning av dinatriumsaltet av 1,3-bis(2-karboxikromon-5-yloxi)propan-2-ol i specifik form
SE8107278A SE442267B (sv) 1976-01-30 1981-12-04 Forfarande for framstellning av en farmaceutisk komposition innehallande dinatriumsaltet av 1,3-bis (2-karboxikromon-5-yloxi)propan-2-ol

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8107278A SE442267B (sv) 1976-01-30 1981-12-04 Forfarande for framstellning av en farmaceutisk komposition innehallande dinatriumsaltet av 1,3-bis (2-karboxikromon-5-yloxi)propan-2-ol

Country Status (14)

Country Link
JP (1) JPS5294411A (hu)
AU (1) AU512593B2 (hu)
DE (1) DE2703119A1 (hu)
DK (2) DK154766C (hu)
ES (1) ES455478A1 (hu)
FI (1) FI770215A (hu)
FR (1) FR2339604A1 (hu)
IE (1) IE44760B1 (hu)
IL (1) IL51314A (hu)
LU (1) LU76661A1 (hu)
NL (1) NL185446C (hu)
NO (2) NO151860C (hu)
NZ (1) NZ183157A (hu)
SE (2) SE442268B (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
GB2077100B (en) * 1980-04-30 1985-04-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
JPS63138228U (hu) * 1987-03-05 1988-09-12
JPS63138229U (hu) * 1987-03-05 1988-09-12
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
DE68915203T2 (de) * 1988-03-22 1994-09-22 Fisons Plc, Ipswich, Suffolk Pharmazeutische Mischungen.
GB8829478D0 (en) * 1988-12-16 1989-02-01 Harris Pharma Ltd Formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
AU663906B2 (en) * 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
ATE171865T1 (de) * 1991-12-12 1998-10-15 Glaxo Group Ltd Arzneimittel
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
DE69218455T2 (de) 1991-12-18 1997-10-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzungen für arzneimittelsuspensionen
WO2000006121A1 (de) 1998-07-24 2000-02-10 Jago Research Ag Medizinische aerosolformulierungen
WO2000007567A1 (de) 1998-08-04 2000-02-17 Jago Research Ag Medizinische aerosolformulierungen
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
ES2691033T3 (es) 2007-02-11 2018-11-23 Map Pharmaceuticals Inc. Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (hu) * 1956-03-21 1900-01-01
BE556587A (hu) * 1957-01-31 1957-04-11
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NZ183157A (en) 1979-08-31
DE2703119C2 (hu) 1990-10-25
JPS5294411A (en) 1977-08-09
NO151860B (no) 1985-03-11
DK357588D0 (da) 1988-06-29
DK38077A (da) 1977-07-31
IL51314A0 (en) 1977-03-31
NO780183L (no) 1977-08-02
LU76661A1 (hu) 1977-08-03
IE44760L (en) 1977-07-30
FR2339604B1 (hu) 1980-12-05
DK156876B (da) 1989-10-16
DK357588A (da) 1988-06-29
SE7700888L (sv) 1977-07-31
FR2339604A1 (fr) 1977-08-26
SE8107278L (sv) 1981-12-04
DK154766B (da) 1988-12-19
JPS6129929B2 (hu) 1986-07-10
IE44760B1 (en) 1982-03-24
DK154766C (da) 1989-05-22
NL185446B (nl) 1989-11-16
SE442267B (sv) 1985-12-16
FI770215A (hu) 1977-07-31
AU2162677A (en) 1978-08-03
NO770286L (no) 1977-08-02
NL7700911A (nl) 1977-08-02
NL185446C (nl) 1990-04-17
NO151860C (no) 1985-06-19
DK156876C (da) 1990-03-12
DE2703119A1 (de) 1977-08-04
AU512593B2 (en) 1980-10-16
ES455478A1 (es) 1978-02-01
IL51314A (en) 1980-03-31

Similar Documents

Publication Publication Date Title
SE442268B (sv) Forfarande for framstellning av dinatriumsaltet av 1,3-bis(2-karboxikromon-5-yloxi)propan-2-ol i specifik form
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
AR224095A1 (es) Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3
AR220892A1 (es) Procedimiento para preparar(piridazinil-3)-5-ditiol-1,2 tiona-3
SE426833B (sv) Forfarande for framstellning av nya gona-4,9(10)-diener
IT1076788B (it) Procedimento per preparare organopolisilossani
SE428687B (sv) Forfarande for framstellning av (3,5-diamino-6-fluor-pyrazinoyl)guanidin
SE7704139L (sv) Forfarande for framstellning av azofergemnen
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
MX4161E (es) Procedimiento de preparacion de compuestos de amino-alcoxi-4(2h)-piranona-2,3 substituidos condensados-5,62
IT1165334B (it) Procedimento per preparare 1,2,3-tiadiazol-5-il-uree
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
RO75589A (ro) Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
IT1065800B (it) Procedimento per preparare trimetil-3,5,5 cicloesen-2 dione-1,4
RO71162A (ro) Procedeu pentru prepararea unor 7-(&-(2,3-dihidro-2-oxo-1h-benzimidazol-1-ilcarbonilamino)-arilacetamidol)-cefalosporine
NO147423C (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater.
SE426947B (sv) Forfarande for framstellning av 3,5,5-trimetyl-hexanoyl-ferrocen
MX4697E (es) Procedimiento para preparar 1,2,3-tiadiazol-5-il-ureas
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
IT1125157B (it) Procedimento per la preparazione di composti,'-dialogeno etilaromatici
IT1087124B (it) Procedimento per preparare idrossi-4 alchil-4 cicloesadien-2,5 one-1
IT1079470B (it) Procedimento per la produzione di 1,2-dicloalcandioni
IT1143595B (it) Procedimento per la produzione di 2,3-cicloalchenopiridine

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7700888-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7700888-6

Format of ref document f/p: F